Analysis of ResMed Inc (RMD)
ResMed Inc (RMD) has been showing some fluctuations in its stock price over the past few days.
On May 31, the closing price was $206.33, slightly lower than the opening price of $209.10. The Relative Strength Index (RSI) of 46.15 indicates a neutral sentiment, neither overbought nor oversold. The Moving Average Convergence Divergence (MACD) is positive at 1.85, but the MACD line is below the signal line, suggesting a potential bearish signal.
Looking at the trend indicators, the Simple Moving Average (SMA) and Exponential Moving Average (EMA) are both above the closing price, indicating a possible downward trend. The Weighted Moving Average (WMA) is also above the closing price, supporting the bearish sentiment.
Overall, based on the technical indicators, ResMed Inc may be facing some downward pressure in the short term. Investors should closely monitor the MACD crossover and moving averages for potential trend reversals.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock outstanding is 15.33 billion shares, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, 200-day moving average of $181.04, and a 52-week range of $164.08 to $199.62.
Lastly, dividends and splits information indicates a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a significant increase in revenue from 2020 to 2021, indicating strong growth.
2. The revenue continued to grow in 2022, reaching its peak.
3. In 2023, there was a slight decrease in revenue compared to the previous year, but it still remained higher than the 2021 figures.
Overall, the company has shown a positive revenue trend over the past four years, with substantial growth up to 2022 and a slight dip in 2023.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been taking on more liabilities over the years, which could indicate increased borrowing or financial obligations.
8. Shareholders' equity has not been growing at the same pace as total assets, indicating that the company may be relying more on debt financing.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020 and its lowest point in 2022.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial performance and cash flow management seem to be influenced by various factors, leading to fluctuations in key metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a range from $1.18 to $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is higher at $1.42, with a range from $1.33 to $1.51. This is also an increase from the EPS of $1.35 in the same quarter a year ago.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from $5.95 to $6.41. This indicates growth from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a range from $5.92 to $7.31. This forecast suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates show a positive trend of increasing earnings per share both in the short term and the long term, indicating potential growth and profitability for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate for the next year is expected to increase to 9.7%.
5. Past 5 Years (per annum): Over the past 5 years, the company has shown a growth rate of approximately 20.1% per annum.
6. Next 5 Years (per annum): Looking ahead, analysts project a growth rate of around 9.7% per annum for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rate expected in the upcoming periods compared to the current and past performance.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential upside according to the analysts' predictions.MACD of RMD